All In Biotech

Free tool

FAERS Monitor: Bimzelx

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 761151 or its brand name (Bimzelx, Bimekizumab-Bkzx). Reports on generic versions are filed under their own applications.

Reports

26,321

Serious

8,343

32% of reports

Hospitalization

2,266

Death reported

184

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • product dose omission issue4,798
  • psoriasis3,204
  • drug ineffective2,544
  • off label use2,157
  • hidradenitis2,041
  • condition aggravated1,885
  • psoriatic arthropathy1,876
  • injection site pain1,487
  • inappropriate schedule of product administration1,205
  • therapy interrupted1,187
  • pruritus1,119
  • pain1,096
  • product availability issue881
  • oral candidiasis856
  • fatigue836

Reports by year received

View as table
YearReports
20161
20191
20203
20216
202213
2023126
20242,720
202510,928
202612,523

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,027,838 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
hidradenitisSignal2,041230.0219.3361,364
oral candidiasisSignal85655.551.842,804
psoriatic arthropathySignal1,87638.737.065,759
product availability issueSignal88132.130.125,536
psoriasisSignal3,20420.119.456,969
therapy interruptedSignal1,18713.512.713,520
product dose omission issueSignal4,79813.212.954,140
inappropriate schedule of product administrationSignal1,2055.45.14,291
condition aggravatedSignal1,8855.04.86,040
injection site painSignal1,4873.93.73,218
pruritusSignal1,1192.32.2862
off label use2,1572.01.91,073
drug ineffective2,5441.51.5518
pain1,0961.41.3143
fatigue8360.90.820

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.